文献速递区域麻醉与超声疼痛医学

神经周围地塞米松安全性的动物实验新证据

A New Step Toward Evidence of In Vivo Perineural Dexamethasone Safety: An Animal Study.
PubMed 文献 · Reg Anesth Pain Med · 2018-01-01

该研究在小鼠坐骨神经阻滞模型中分析神经周围地塞米松与罗哌卡因联用的组织学神经毒性。90只小鼠随机分为5组,结果显示各组华勒变性和神经周围炎症无统计学差异,而罗哌卡因联合神经周围地塞米松组的感觉和运动阻滞持续时间均显著长于单用罗哌卡因组或罗哌卡因联合全身地塞米松组。

要点

  • 神经周围地塞米松不增加小鼠坐骨神经华勒变性或神经周围炎症。
  • 罗哌卡因联合神经周围地塞米松的感觉阻滞持续时间长于单用罗哌卡因或联合全身地塞米松。
  • 罗哌卡因联合神经周围地塞米松的运动阻滞持续时间亦长于其他组。

核心结论

  • 罗哌卡因联合神经周围地塞米松可延长感觉阻滞持续时间,且不增加神经毒性。

研究设计与样本

  • 研究对90只小鼠行坐骨神经阻滞,随机分为5组,每组18只。
  • 各组分别为假手术组(等渗盐水)、R组(神经周围罗哌卡因)、D组(神经周围地塞米松)、RDPN组(神经周围罗哌卡因+神经周围地塞米松)和RDS组(神经周围罗哌卡因+全身地塞米松)。
  • 每30分钟评估感觉和运动阻滞,持续14小时;术后14天和28天每组处死9只小鼠进行坐骨神经组织学评估。

主要发现

  • 华勒变性在组间无统计学差异(第14天P=0.28,第28天P=0.22)。
  • 神经周围炎症在组间无统计学差异(第14天P=0.9)。
  • 运动阻滞持续时间:RDPN组150分钟(127-172分钟),RDS组120分钟(90-120分钟),R组60分钟(60-90分钟),组间有统计学差异。
  • 感觉阻滞持续时间:RDPN组660分钟(660-720分钟),RDS组480分钟(427-660分钟),R组330分钟(240-410分钟),组间有统计学差异。

临床怎么用

  • 临床可考虑神经周围地塞米松与罗哌卡因联用以延长感觉阻滞,但需结合动物实验结论谨慎外推。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVES: The aim of this study was to analyze histological nerve toxicity of perineural dexamethasone administration in combination with ropivacaine on mice. Efficacy of perineural dexamethasone in combination with regional anesthesia is clearly demonstrated. However, the safety of this procedure is still a matter of debate. METHODS: A sciatic nerve block was performed on 90 mice. Five groups, each containing 18 mice assigned randomly, were used in these experiments: the sham group (isotonic saline solution), R group (perineural ropivacaine), D group (perineural dexamethasone), RDPN group (perineural ropivacaine and perineural dexamethasone), and the RDS group (perineural ropivacaine and systemic dexamethasone). Sensory and motor blocks were evaluated every 30 minutes for 14 hours. Fourteen and 28 days after this procedure, 9 mice in each group were killed for sciatic nerve histological assessment. RESULTS: No statistical difference was observed between different groups for Wallerian degeneration (P = 0.28 at day 14 and P = 0.22 at day 28) and perineural inflammation (P = 0.9 at day 14). Motor and sensory block durations were tested for each group. A statistical difference was observed for motor block duration between the RDPN group (150 minutes [127-172 minutes]), the RDS group (120 minutes [90-120 minutes]), and the R group (60 minutes [60-90 minutes]). Sensory block duration was also statistically different: 660 minutes (660-720 minutes) in the RDPN group, 480 minutes (427-660 minutes) in RDS group, 330 minutes (240-410) in the R group. CONCLUSIONS: A combination of ropivacaine and perineural dexamethasone allows longer sensory block duration compared with ropivacaine alone or ropivacaine and systemic dexamethasone, without increased neural toxicity.

来源:Reg Anesth Pain Med,查看原文。版权归原作者所有。

引用

  1. Marty P, Bennis M, Legaillard B, et al. A New Step Toward Evidence of In Vivo Perineural Dexamethasone Safety: An Animal Study. Reg Anesth Pain Med. 2018. PMID: 28394848. doi:10.1097/AAP.0000000000000392

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。